Alnylam Pharmaceuticals
ALNY
#632
Rank
C$45.13 B
Marketcap
$348.61
Share price
-0.28%
Change (1 day)
76.18%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

Market capitalization of Alnylam Pharmaceuticals (ALNY)

Market cap: C$45.13 Billion

As of March 2025 Alnylam Pharmaceuticals has a market cap of C$45.13 Billion. This makes Alnylam Pharmaceuticals the world's 632th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Alnylam Pharmaceuticals from 2004 to 2025

End of year Market Cap

Year Marketcap Change
2025C$45.13 B2.46%
2024C$44.04 B38.25%
2023C$31.85 B-19.7%
2022C$39.67 B53.49%
2021C$25.84 B34.25%
2020C$19.25 B14.09%
2019C$16.87 B67.93%
2018C$10.04 B-36.56%
2017C$15.84 B266.89%
2016C$4.31 B-61.14%
2015C$11.11 B27.87%
2014C$8.69 B99.19%
2013C$4.36 B358.01%
2012C$0.95 B168.93%
2011C$0.35 B-15.13%
2010C$0.41 B-46.2%
2009C$0.77 B-37.71%
2008C$1.24 B5.28%
2007C$1.18 B28.13%
2006C$0.92 B207.78%
2005C$0.29 B73.36%
2004C$0.17 B

End of Day market cap according to different sources

On Mar 12th, 2025 the market cap of Alnylam Pharmaceuticals was reported to be:

C$45.25 Billion
by Yahoo Finance info icon info icon
C$45.25 Billion
by CompaniesMarketCap info icon info icon
C$45.25 Billion
by Nasdaq info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
C$2.98 B-93.39%๐Ÿ‡บ๐Ÿ‡ธ USA
C$107.29 B 137.75%๐Ÿ‡บ๐Ÿ‡ธ USA
C$13.76 B-69.50%๐Ÿ‡บ๐Ÿ‡ธ USA
C$1.66 B-96.31%๐Ÿ‡บ๐Ÿ‡ธ USA
C$0.13 B-99.71%๐Ÿ‡บ๐Ÿ‡ธ USA
C$311.78 B 590.86%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
C$210.71 B 366.91%๐Ÿ‡ซ๐Ÿ‡ท France
C$27.19 B-39.74%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel